SEATTLE, March 8 /PRNewswire-FirstCall/ -- Pacific Biomarkers, Inc. (“PBI”), a leading provider of specialized biomarker and contract research services, today announced that the trading symbol for its common stock has been changed from “PBME” to “PBMC”. Effective today, March 8, 2010, the stock is trading on the OTC Bulletin Board under its new “PBMC” symbol.
PBI is headquartered in Seattle, Washington, and its common stock trades on the OTC Bulletin Board under the symbol “PBMC”. For more information about PBI, visit the company’s web site at www.pacbio.com.
CONTACT: Ron Helm, CEO of Pacific Biomarkers, Inc., +1-206-298-0068; or RJ
Falkner & Company, Inc., Investor Relations Counsel, 1-800-377-9893,
info@rjfalkner.com, for Pacific Biomarkers, Inc.
Web site: http://www.pacbio.com/
